Table 4.
Authors | Number of patients | aPL (%) | aCL‐IgG (%) | aCL‐IgA (%) | aCL‐IgM (%) | aβ2GPI‐IgG (%) | aβ2GPI‐IgA (%) | aβ2GPI‐IgM (%) |
---|---|---|---|---|---|---|---|---|
Merkel et al10 | 70 | 15.7 | 11.4 | 0 | 4.3 | ‐ | ‐ | ‐ |
Wolf et a11 | 173 | 32 | 20 | ‐ | 16 | ‐ | ‐ | ‐ |
Ambrozic et al8 | 53 | 23 | 8 | 17 | 8 | 6 | 8 | 11 |
Pahor et al7 | 70 | 37 | 12.8 | ‐ | 4.3 | 10 | 25.7 | 2.8 |
Palomo et al9 | 84 | 19.1 | 8.3 | 0 | 2.4 | 7.2 | 0 | 4.8 |
Our study | 90 | 35.5 | 8.9 | 4.4 | 6.7 | 6.7 | 26.7 | 5.6 |